Unknown

Dataset Information

0

Design, Synthesis and Evaluation of Substituted Aryl-2-Nitrovinyl Derivatives as Small Molecules Proteasome Inhibitors.

ABSTRACT: Based on the existing structure activity relationship for proteasome inhibitors, a number of substituted aryl-2-nitrovinyl derivatives have been synthesized as Michael acceptor and their cytotoxicity and proteasome inhibitory effects were evaluated on two cancer cell lines. Compound 2d exhibited IC50 values of 0.71 and 17.79 ?M comparable to bortezomib against MCF-7 and PC-3, respectively. The results show that the electronic properties and steric hindrance can affect the interaction of these small molecules with their receptor at the active site of the enzyme while the presence of CH2OH group on ?-carbon of Michael acceptor is favorable, and para substitution of OMe on phenyl ring of ?-carbon can increase the inhibitory potencies. Molecular docking studies confirm our experimental findings about mode of binding of our compounds with 20S proteasome.

SUBMITTER: Faghih Akhlaghi M 

PROVIDER: S-EPMC6094432 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, Synthesis and Evaluation of Substituted Aryl-2-Nitrovinyl Derivatives as Small Molecules Proteasome Inhibitors.

Faghih Akhlaghi Masoud M   Daeihamed Marjan M   Ayatollahi Seyed Abdolmajid SA   Kobarfard Farzad F   Ata Athar A  

Iranian journal of pharmaceutical research : IJPR 20180101 3

Based on the existing structure activity relationship for proteasome inhibitors, a number of substituted aryl-2-nitrovinyl derivatives have been synthesized as Michael acceptor and their cytotoxicity and proteasome inhibitory effects were evaluated on two cancer cell lines. Compound 2d exhibited IC<sub>50</sub> values of 0.71 and 17.79 μM comparable to bortezomib against MCF-7 and PC-3, respectively. The results show that the electronic properties and steric hindrance can affect the interaction  ...[more]

Similar Datasets

Unknown Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation.
| S-EPMC5748275 | biostudies-literature
Unknown Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors.
| S-EPMC9463491 | biostudies-literature
Unknown Design, Synthesis and Antibacterial Evaluation of 3-Substituted Ocotillol-Type Derivatives.
| S-EPMC6321515 | biostudies-other
Unknown Design, Synthesis and Biological Evaluation of N,N-Substituted Amine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors.
| S-EPMC6151529 | biostudies-literature
Unknown Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors.
| S-EPMC3734177 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of novel N 4 -substituted sulfonamides: acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors.
| S-EPMC6661844 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors.
| S-EPMC10819570 | biostudies-literature
Unknown Design, Synthesis, and Herbicidal Activity Evaluation of Novel Aryl-Naphthyl Methanone Derivatives.
| S-EPMC6349756 | biostudies-literature
Unknown Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors.
| S-EPMC10039877 | biostudies-literature
Unknown Design, synthesis, and evaluation of cystargolide-based ?-lactones as potent proteasome inhibitors.
| S-EPMC6168434 | biostudies-literature